
Aster Biopharma LLP
About Aster Biopharma LLP
Data last updated:
Aster Biopharma LLP was a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. The LLP has been converted into a company and no longer exists as an LLP. For the latest details, refer to the successor company. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 August 2022.
The LLP was registered with the Registrar of Companies (ROC), Mumbai, under LLPIN ABC-0450. Its GSTIN is 27ABZFA2494A1Z7 (Maharashtra).
The LLP had a total obligation of contribution of βΉ50 Lakh. It was led by designated partners Ruchi Nimish Siria and Agam Lalit Shah.
Its latest statement of accounts is for the year ended 31 March 2023. The registered office was at Mumbai, Maharashtra.
Company details
Contact details
Aster Biopharma LLP's registered office is in Mumbai, Maharashtra.
- Registered Address616/1 11th Floor Shree Radhe Empire, Chandavarkar Road, Mumbai, Maharashtra, India β 400092
- IndustryPharma, Drug Formulation & Development, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aster Biopharma LLP
FY 2023 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2022-23 |
|---|---|
| Income and Expenditure | |
| Turnover | |
| Other Income | |
| Total Income | |
| Purchases and Direct Costs | |
| Personnel Expenses | |
| Administrative Expenses | |
| Interest | |
| Depreciation | |
| Total Expenses | |
| Profit Before Tax | |
| Tax | |
| Profit After Tax | |
| Profit Transferred to Partners | |
| Assets and Liabilities | |
| Partners' Contribution | |
| Reserves and Surplus | |
| Secured Loans | |
| Unsecured Loans | |
| Trade Payables | |
| Other Liabilities and Provisions | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Loans and Advances | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 |
|---|---|
| Profitability | |
| Net Profit Margin | |
| Return on Partners' Funds | |
| Return on Assets | |
| Liquidity and Debt | |
| Current Ratio | |
| Debt to Partners' Funds | |
| Interest Coverage | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Turnover Growth | |
| Profit Growth | |
To see the full financial statements and ratios of Aster Biopharma LLP, buy the company report.
Designated partners of Aster Biopharma LLP
Aster Biopharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ruchi Nimish Siria | Designated Partner | 11 Aug 2022 | 4 Years 3 Months | As last reported |
| Agam Lalit Shah Also directs: Kwai Healthcare Private Limited, Aster Life Care Private Limited, Aster Biopharma Private Limited and 1 more | Designated Partner | 11 Aug 2022 | 4 Years 3 Months | As last reported |
Legal cases
No court or tribunal cases involving Aster Biopharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aster Biopharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aster Biopharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABZFA2494A1Z7 | Maharashtra | Active | 29 Sep 2022 |
To see the full GST registrations and return filing status of Aster Biopharma LLP, buy the company report.
Recent activity
Aster Biopharma LLP has 2 designated partner changes on record since 2022: 2 appointments. The latest: Agam Lalit Shah was appointed as Designated Partner on 11 Aug 2022.
Frequently asked questions
Aster Biopharma has been converted into a company - the business changed its legal structure from a Limited Liability Partnership to a company. The LLP no longer exists in its previous form. For the latest information, refer to the successor company registered with MCA.
Aster Biopharma was a limited liability partnership based in Mumbai, Maharashtra, India. The LLP worked in drug formulation and development, within the pharma industry. It was incorporated on 11 August 2022 and is registered under LLPIN ABC-0450. For the latest details, refer to the successor company.
The LLPIN (Limited Liability Partnership Identification Number) of Aster Biopharma is ABC-0450. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Aster Biopharma had 2 designated partners:
- Ruchi Nimish Siria - Designated Partner
- Agam Lalit Shah - Designated Partner
Aster Biopharma was incorporated on 11 August 2022. It is registered with the Registrar of Companies, Mumbai.
The registered office of Aster Biopharma is at 6161 11th Floor Shree Radhe Empire, Chandavarkar Road, Mumbai, Maharashtra, India β 400092.
The latest financial statements of Aster Biopharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 March 2023. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Aster Biopharma is 27ABZFA2494A1Z7, registered in Maharashtra.
Aster Biopharma operated in the pharma industry, in the drug formulation and development segment.
Agam Lalit Shah was appointed as Designated Partner on 11 Aug 2022. Ruchi Nimish Siria was appointed as Designated Partner on 11 Aug 2022.

